Shares of IQVIA Holdings Inc. IQV rose 1.58% to $153.48 Friday, on what proved to be an all-around favorable trading session ...

Shares of IQVIA Holdings Inc. IQV shed 2.56% to $151.10 Thursday, on what proved to be an all-around great trading session ...

IQVIA Holdings Inc. IQV will release its first-quarter 2025 results on May 6, before market open. IQV has a decent earnings ...

Wall Street analysts expect IQVIA Holdings (IQV) to post quarterly earnings of $2.63 per share in its upcoming report, which indicates a year-over-year increase of 3.5%. Revenues are expected to be $3 ...

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Eli Lilly's weekly prescription data for Zepbound is up 354% year over year while Novo Nordisk's Wegovy is up just 61%.

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $227.67, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

HSBC analyst Sidharth Sahoo downgraded Iqvia (IQV) to Hold from Buy with a price target of $160, down from $260. The firm adjusted ratings in ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced today that the ...